Vermont (VT) Business Law CLE Course Catalog

The Small Business Reorganization Act of 2019 went into effect a mere few weeks before a worldwide pandemic unfolded, setting into motion unforeseen challenges and learning curves for the entire bankruptcy court system. This session consists of two mock presentations that will demonstrate the application of technology in the pre-trial practice and trial presentation of a subchapter V virtual trial. Included in these presentations will be virtual depositions and document preparation and organization, as well as the nontechnical challenges these cases can face, such as feasibility, projected-income issues, best practices assuming a nonconsensual plan, and cramdown. During the mock presentations, a team of technology experts will interject real-time, practical tips on the risks, benefits and potential ethical pitfalls of technology use in virtual trials, and much more.

A review of relevant statutory and case authority surrounding issues of fraud and plan confirmation. What is fraudulent? What is ethical? What is simply good lawyering? This program will explore these and other concerns around claims trading and the potential for manipulation of the bankruptcy plan process.

This panel will discuss various issues and challenges accompanying sales of health care assets, including factors to consider in determining whether or not a sale is the best alternative. Such factors include the role of regulatory authorities, political challenges, reimbursement issues, issues related to urban vs. rural facilities, the evolution of the health care business, and best practices in navigating such challenges.

This panel will present a primer on the U.S. pharmaceutical industry, focusing on the typical capital structures of pharmaceutical/development companies versus in-pipeline companies. The panelists will examine the factors leading to the recent surge in pharmaceutical bankruptcy cases and their outcomes/resolutions, as well as ? 363 sales of pharmaceutical companies’ assets and restructurings. Opiate bankruptcy cases such as Purdue and Mallinckrodt will be highlighted, as will ancillary issues that arise in pharmaceutical bankruptcy cases, such as product recalls, regulatory issues (such as with the FDA) and IP licensing issues.

The Small Business Restructuring Act of 2019 is one of the most important pieces of bankruptcy legislation passed since BAPCPA in 2005. This session will offer a deep dive into the practical aspects of the new Subchapter V of the Bankruptcy Code, offering insights into emerging case law, recent adjustments enacted by the CARES Act of 2020, and how to guide clients through a small business case from inception to confirmation.

This session features a panel discussion of recent developments in commercial cases involving insurance, trademark, WARN Act and marijuana issues.

Join the expert-authors behind Tax Facts in this seminar as they discuss important questions many will have about the state of tax in 2021, including potential changes, implications, and more.

Hear from leaders who have developed and implemented successful crisis management plans, including Who to involve in the creation of your crisis management plan; Actionable first steps to take when you find yourself in a PR crisis; Strategies for monitoring borderline incidents and determining when to step in.

In this session, we will explore best practices for managing a team through a crisis, the internal communications to reassure and support your team and how to re-organize to maximize your resources during these times.